Unity Biotechnology, Inc. Proceeds from Common Stock Issued
Unity Biotechnology, Inc. reported Proceeds from Common Stock Issued of $8.89 million for the 6-month period ending 2021-06-30, per its 10-Q filed 2021-08-10.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2021-08-10
- Unity Biotechnology, Inc. proceeds from issuance of common stock for the quarter ending 2021-06-30 was $1.00K, a 100.00% decline year-over-year.
- Unity Biotechnology, Inc. proceeds from issuance of common stock for the quarter ending 2021-03-31 was $8.89M, a 1.47% increase year-over-year.
- Unity Biotechnology, Inc. proceeds from issuance of common stock for the quarter ending 2020-12-31 was $0.00, a 100.00% decline year-over-year.
- Unity Biotechnology, Inc. proceeds from issuance of common stock for the quarter ending 2020-09-30 was $7.78M.
- Unity Biotechnology, Inc. proceeds from issuance of common stock for fiscal 2020 was $37.27M, a 42.88% increase from fiscal 2019.
- Unity Biotechnology, Inc. proceeds from issuance of common stock for fiscal 2019 was $26.09M.
- Unity Biotechnology, Inc. proceeds from issuance of common stock for fiscal 2018 was $0.00.
| Period end | Proceeds from Issuance of Common Stock 3 month | Proceeds from Issuance of Common Stock 6 month | Proceeds from Issuance of Common Stock 9 month | Proceeds from Issuance of Common Stock 12 month |
|---|---|---|---|---|
| 2021-06-30 | $1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | $8.89M 10-Q · filed 2021-08-10 | $8.89M derived: sum of 3 quarters · filed 2021-08-10 | $16.67M derived: sum of 4 quarters · filed 2021-08-10 |
| 2021-03-31 | $8.89M 10-Q · filed 2021-05-11 | $8.89M derived: sum of 2 quarters · filed 2021-05-11 | $16.67M derived: sum of 3 quarters · filed 2021-05-11 | $37.40M derived: sum of 4 quarters · filed 2021-08-10 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-23 | $7.78M derived: sum of 2 quarters · filed 2021-03-23 | $28.51M derived: sum of 3 quarters · filed 2021-08-10 | $37.27M 10-K · filed 2021-03-23 |
| 2020-09-30 | $7.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | $28.51M derived: sum of 2 quarters · filed 2021-08-10 | $37.27M 10-Q · filed 2020-11-04 | $57.96M derived: sum of 4 quarters · filed 2021-08-10 |
| 2020-06-30 | $20.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | $29.49M 10-Q · filed 2021-08-10 | $50.18M derived: sum of 3 quarters · filed 2021-08-10 | |
| 2020-03-31 | $8.76M 10-Q · filed 2021-05-11 | $29.45M derived: sum of 2 quarters · filed 2021-05-11 | ||
| 2019-12-31 | $20.69M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-23 | $26.09M 10-K · filed 2021-03-23 | ||
| 2019-09-30 | $5.40M 10-Q · filed 2020-11-04 | |||
| 2018-12-31 | $0.00 10-K · filed 2021-03-23 |